In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive employment news from Baxter International and Conformis, the hopeful news from Edwards Lifesciences, and the cautionary tone from Medtronic. What can we expect from the rest of medtech?

In the first half of the podcast, we examine comments from Edwards’ Q1 call. The company is warning analysts about a rough second quarter but explains why the situation may improve in the second half of the year.

For a look at the state of clinical trials in medtech, we talk with Mark McIlduff, general manager, U.S., at the newly named CRO, Avania. McIlduff walks us through how clinical trials were shut down by the Covid-19 crisis and what it might take to get them started in the future.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.